Nexten "Acquires 10 Billion KRW Worth of Shares in Subsidiary NexIDLab"

[Asia Economy Reporter Hwang Yoon-joo] Nexten announced on the 9th that it will acquire 1.98 million shares of NexID Lab, a subsidiary (planned) for discovering and evaluating domestic and international pharmaceutical bio ventures, for approximately 10 billion KRW.

After acquiring the shares, Nexten's stake in NexID Lab will be 100%. The scheduled date for the share acquisition is the same day as the announcement. Nexten stated that the purpose of this share acquisition is "entry into new business."